Susan Silbermann

During a 30 year career at Pfizer, Ms. Silbermann held numerous leadership positions in marketing, commercial development, and general management in the U.S. and international markets. Prior to her retirement in May 2021, Ms. Silbermann chaired Pfizer’s Global COVID-19 Task Force. At the same time, Ms. Silbermann served as Pfizer’s Global President, Emerging Markets, where she oversaw operations across marketing, medical, sales, access, and government affairs in China, Asia, Latin America, Africa, and the Middle East. In this role, she designed and implemented a new innovation-focused organization in China, working in close collaboration with both the central government and the provinces to address their specific healthcare needs. From 2012 until 2018, Ms. Silbermann served as President and General Manager of Pfizer Vaccines. In this role, Ms. Silbermann was responsible for both the commercial development and operational management of Pfizer’s portfolio of preventative and therapeutic vaccines. She was also a member of the board of Gavi, the Vaccine Alliance from 2017 until 2020. From 2008 until 2012, she was the regional president of Latin America within Pfizer’s Emerging Markets Business Unit where she managed Pfizer’s pharmaceutical operations in this diverse region. Ms. Silbermann earned a bachelor’s degree in biology and French from Tufts University, and masters’ degrees in international business and French studies from the Stern Graduate School of Business and the Institute of French Studies at New York University.